Opinion
Video
Clinical Presentation of Arrhythmias
Experts discuss the growing role of early detection and predictive strategies in managing arrhythmias—particularly atrial fibrillation—highlighting the impact of wearable technology, challenges in diagnosis due to intermittent symptoms, and the shift toward more personalized, value-based care driven by timely evaluation and evidence-based interventions.
The discussion opened with a focus on arrhythmias, highlighting their prevalence and the growing interest in improving outcomes through earlier detection and predictive strategies. Arrhythmias present in various forms, but atrial fibrillation stands out as the most frequently encountered, both in diagnosed cases and in patients presenting with symptoms suggestive of the condition. It's often discovered incidentally or in patients with risk factors such as prior cerebrovascular events. The importance of timely diagnosis is emphasized, given that management strategies differ significantly depending on the specific arrhythmia type.
In clinical practice, the spectrum of arrhythmias includes supraventricular tachycardia, ventricular arrhythmias, and heart blocks, though these are generally less common than atrial fibrillation. Many patients are referred for evaluation after experiencing symptoms such as palpitations, lightheadedness, dizziness, or even near-syncope. These symptoms can be intermittent and sometimes attributed to anxiety, making diagnosis challenging. Importantly, some cases of arrhythmia are detected following significant cardiac events or are identified during the course of evaluating unexplained symptoms.
Technology is playing a growing role in arrhythmia detection. An increasing number of patients now present with data from wearable devices such as smartwatches, which alert them to irregular rhythms or signs of atrial fibrillation. While these devices are not diagnostic tools on their own, they often prompt timely clinical evaluation. This shift toward proactive and patient-driven detection is shaping new opportunities for intervention and care optimization. It also emphasizes the need for clinicians to interpret these findings within the broader context of clinical assessment and to apply evidence-based practices when determining next steps in care. Ultimately, these developments are contributing to more personalized, value-based care approaches in cardiology.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
